secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001640334-24-000271
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria raises $3.6M in registered direct offering and private placement
------------------------------------------------------------------------

- Gross proceeds of ~$3.6M from issuance of 1,558,443 shares at $2.31/share and pre-funded warrants at $2.3099.
- Private placement issued unregistered warrants for up to 1,558,443 shares at $2.185 exercise price, 5-year term.
- Net proceeds earmarked for R&D studies, patent/legal costs, and general working capital.
- H.C. Wainwright acted as exclusive placement agent; fees equal 7% (6% for one investor) of gross proceeds plus agent warrants.
- Officers and directors subject to 30-day lock-up on common stock and equivalents post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/0001640334-24-000271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424000271/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-000271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer